These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19464164)

  • 1. Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer.
    Straver ME; Rutgers EJ; Russell NS; Oldenburg HS; Rodenhuis S; Wesseling J; Vincent A; Peeters MT
    Eur J Cancer; 2009 Sep; 45(13):2284-92. PubMed ID: 19464164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
    van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
    Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
    Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
    Javid S; Segara D; Lotfi P; Raza S; Golshan M
    Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
    Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
    Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
    Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
    Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
    Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis.
    Rebollo-Aguirre AC; Gallego-Peinado M; Sánchez-Sánchez R; Pastor-Pons E; García-García J; Chamorro-Santos CE; Menjón-Beltrán S
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):240-5. PubMed ID: 23684711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer.
    Baruah BP; Goyal A; Young P; Douglas-Jones AG; Mansel RE
    Br J Surg; 2010 May; 97(5):680-3. PubMed ID: 20186888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictors of axillary node metastasis at breast surgery after neoadjuvant chemotherapy in patients with pre- chemotherapy-sentinel node positive breast cancer].
    Tokita H; Aruga T; Yamashita T; Saji S; Suzuki E; Horiguchi K; Kitagawa D; Sekine S; Horiguchi S; Hirashima Y; Kuroi K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1639-45. PubMed ID: 21996959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of response evaluation methods of neoadjuvant chemotherapy in breast cancer patients].
    Sun B; Song ST; Wu SK; Jiang ZF; Wang T; Zhang SH; Zhao YB; Yu CZ; Li XB; Yang T; Li GJ
    Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):783-5. PubMed ID: 20021835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
    Patel NA; Piper G; Patel JA; Malay MB; Julian TB
    Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
    Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA
    Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy.
    van Rijk MC; Deurloo EE; Nieweg OE; Gilhuijs KG; Peterse JL; Rutgers EJ; Kröger R; Kroon BB
    Ann Surg Oncol; 2006 Jan; 13(1):31-5. PubMed ID: 16372147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.